Novavax jab triggers immune response to Omicron | Financial Times
Asia's curious struggle to vaccinate its citizens | Financial Times
How to tackle vaccine hesitancy | Financial Times
Europe approves Novavax Covid shot | Financial Times
How to vaccinate the world | Financial Times
Covid pandemic triggers drop in routine childhood vaccinations | Financial Times
Coronavirus tracker: the latest figures as countries fight the Covid-19 resurgence | Free to read | Financial Times
UK approves Oxford/AstraZeneca vaccine | Financial Times
Covid vaccines show few serious side-effects after millions of jabs | Financial Times
Covid-19 vaccine tracker
How effective are coronavirus vaccines against the Delta variant? | Financial Times
London lags behind as the UK's vaccine rollout gathers pace | Financial Times
Vaccines vs variants: the race to immunise the developing world | Financial Times
US FDA panel backs Novavax Covid jab with hopes of persuading sceptics | Financial Times
Nein Danke': the resistance to Covid-19 vaccines in German-speaking Europe | Financial Times
Covid passes boosted economies and vaccine uptake, study shows | Financial Times
Vaccine milestone as global Covid jabs pass number of confirmed cases | Financial Times
Demand for Covid vaccines falls amid waning appetite for booster shots | Financial Times
Swiss medical regulator rejects Oxford/AstraZeneca Covid vaccine | Financial Times
A global database of COVID-19 vaccinations | Nature Human Behaviour
EU hit by delay to Oxford/AstraZeneca vaccine delivery | Financial Times
US FDA panel backs Novavax Covid jab with hopes of persuading sceptics | Financial Times
London lags behind as the UK's vaccine rollout gathers pace | Financial Times
COVID-19 vaccine tracker and landscape
Covid vaccine development: The shots available and the doses administered | Financial Times
